ICD-10-CM Billable Code

M08.912

Juvenile arthritis, unspecified, left shoulder

Clinical Classification Guidelines

Medical Intelligence & Overview

Juvenile arthritis, also known as juvenile idiopathic arthritis (JIA), is a term used to describe a group of autoimmune conditions that cause persistent inflammation in the joints of children and adolescents. When this inflammation affects the left shoulder, it can lead to pain, swelling, and reduced movement, impacting daily activities and overall quality of life. The ICD-10 code M08.912 specifically refers to a case of juvenile arthritis that affects the left shoulder without further specification of the subtype.

Causes & Symptoms

Clinical Causes: Autoimmune response where the body's immune system mistakenly attacks joint tissues. Genetic predisposition, with family history increasing risk. Environmental factors that might trigger immune dysfunction, such as infections. Possible environmental or internal triggers that may initiate immune activity affecting joint tissues. Lack of a clear causative agent makes juvenile arthritis a complex condition influenced by multiple factors.

Key Symptoms: Persistent pain in the left shoulder that may worsen with activity or during periods of rest. Swelling or tenderness around the shoulder joint. Stiffness, especially in the morning or after periods of inactivity. Limited range of motion or difficulty moving the affected shoulder. Warmth or redness over the joint. Possible development of joint deformities if the condition persists or worsens. General fatigue or signs of systemic inflammation, such as fever or rash, in some cases.

Diagnostic & Treatment

Diagnosis Path: Diagnosis involves a combination of clinical evaluation, medical history review, and diagnostic tests. Healthcare providers may perform physical examinations to assess joint swelling, warmth, and movement. Blood tests can help identify markers of inflammation or autoimmune activity, such as elevated ESR or CRP levels. Imaging studies like X-rays, ultrasound, or MRI scans help visualize joint damage or inflammation, although early stages may not show significant changes. Because juvenile arthritis can mimic other conditions, thorough assessment is essential for accurate diagnosis.

Treatment Protocols: Nonsteroidal anti-inflammatory drugs (NSAIDs) to reduce pain and swelling. Disease-modifying antirheumatic drugs (DMARDs), such as methotrexate, to slow disease progression. Biologic agents targeting specific immune pathways involved in inflammation. Physical and occupational therapy to improve joint function and maintain mobility. Regular exercise to strengthen muscles around the joint and support joint integrity. Joint supports or braces if necessary to stabilize the shoulder during activity. Monitoring and managing possible side effects of medications with healthcare supervision.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is M08.912 a billable ICD-10 code?
Yes, M08.912 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report M08.912?
Clinical documentation must specify the nature of Juvenile arthritis, unspecified, left shoulder and any associated comorbidities for accurate reporting.

Cite this Clinical Reference